Comparison of two doses of leucovorin in severe low-dose methotrexate toxicity – a randomized controlled trial
Abstract Background Leucovorin (folinic acid) is a commonly used antidote for severe toxicity with low-dose methotrexate, but its optimum dose is unclear, varying from 15 to 25 mg every 6-h. Methods Open-label RCT included patients with severe low-dose (≤ 50 mg/week) methotrexate toxicity defined as...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2023-05-01
|
| Col·lecció: | Arthritis Research & Therapy |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s13075-023-03054-2 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
